list of glp 1 agonist drugs GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More GLP-1 Medications | Inspira Health

Injectable GLP-1 drugs will continue to be developed, with Novo Nordisk advancing multiple candidates

As of January 6, 2025 here is a list of approved and pending new GLP-1 agonists class of medications that can help manage Type 2 diabetes and obesity: Ozempic (semaglutide) Approved - A weekly injectable GLP-1 receptor agonist that helps regulate blood sugar and suppress appetite, promoting weight loss in addition to managing type 2 diabetes

Some people also experience dizziness, increased heart rate, infections, headaches, upset stomach or redness or itchiness at the injection site

Emerging Trends and Market Dynamics The GLP-1 market is poised for significant growth, with Novo Nordisk and Eli Lilly set to launch new injectables and oral formulations

however, most phase III clinical studies are of insufficient duration and do not include enough study participants to effectively gauge long-term safety